Centers for Disease Control and Prevention - ERA

Description

The purpose and overarching goal of this cooperative agreement is to address the high prevalence of viral hepatitis C infection by developing and implementing an integrated approach for detection, prevention, care and treatment of Hepatitis C infection among young (18-30 year old), non-urban people who inject drugs (PWID). Awardees will develop and implement a comprehensive strategy to enroll young non-urban PWID, collect epidemiological information, test for HCV infection and provide linkage to primary care services and prevention-based education. In addition to providing hepatitis C virus (HCV) testing, awardees will provide testing for the presence of co-infections with hepatitis B virus (HBV) and HIV. Rates of HCV infection or re-infection will be evaluated through follow-up assessment.

Who can apply

• Others

Contact

Centers for Disease Control and Prevention (CDC) <br/>Procurement and Grants Office (PGO) <br/>Phone: 770-488-2700 <br/> <br/>
pgotim@cdc.gov